Securities code: Shan Dong Kexing Bioproducts Co.Ltd(688136) securities abbreviation: Shan Dong Kexing Bioproducts Co.Ltd(688136) Announcement No.: 2022021 Shan Dong Kexing Bioproducts Co.Ltd(688136)
Announcement of resolutions of the 18th meeting of the first board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
Shan Dong Kexing Bioproducts Co.Ltd(688136) (hereinafter referred to as “the company”) the 18th meeting of the first board of supervisors was held on April 15, 2022 in the form of on-site communication. The notice of the meeting was issued on April 5, 2022. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting.
The meeting was presided over by Huang Kaikun, chairman of the board of supervisors. The meeting shall be held in accordance with relevant laws, regulations, rules and the articles of association.
2、 Deliberation at the meeting of the board of supervisors
(I) deliberated and passed the proposal on the work report of the board of supervisors in 2021
The board of directors and supervisors shall be responsible for the performance of their duties in accordance with the company law and the company’s rules and regulations, and shall be responsible for the performance of their duties in strict accordance with the company’s rules and regulations. All supervisors of the company performed their duties with due diligence, ensured the standardized operation of the company and the accuracy and integrity of assets and finance, and safeguarded the legitimate rights and interests of the company and shareholders.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the general meeting of shareholders of the company for deliberation.
(II) deliberated and passed the proposal on the company’s 2021 annual report and its summary
The board of supervisors of the company believes that the preparation and review procedures of the company’s 2021 annual report and its summary comply with relevant laws and regulations, the articles of association and other provisions, and can fairly reflect the company’s financial status and operating results in 2021. The board of supervisors and all supervisors guarantee that the information disclosed in the company’s 2021 annual report and its abstract is true, accurate and complete, and that the information contained therein does not contain any false records, misleading statements or major omissions, and shall bear legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law. Agree to the contents of Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 annual report and its summary.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) disclosed by the company on the same day Summary of Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 annual report and full text of Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 annual report.
3、 Deliberated and passed the proposal on the company’s 2021 annual financial statement report
The financial statement report of Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 objectively, truly and accurately reflects the financial situation and operating results of the company in 2021, and agrees with the contents of the report.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the general meeting of shareholders of the company for deliberation.
4、 Deliberated and passed the proposal on the evaluation report of internal control in 2021
In accordance with the provisions of the basic norms of enterprise internal control, the company has evaluated the effectiveness of the company’s internal control and issued the company’s 2021 internal control evaluation report. Through the understanding of the company’s current internal control system and its implementation, we believe that the evaluation report objectively and truly reflects the real situation of the company’s internal system construction and internal control system implementation.
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) disclosed by the company on the same day Internal control evaluation report in 2021.
5、 The proposal on the company’s profit distribution plan for 2021 was reviewed and approved
The company’s profit distribution plan for 2021 fully considers the company’s profitability, cash flow, capital demand and other factors, which is conducive to the sustainable and stable development of the company and does not damage the interests of the company and shareholders, especially minority shareholders. The board of supervisors unanimously agreed to the 2021 profit distribution plan and agreed to submit the proposal to the 2021 annual general meeting of shareholders of the company for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the general meeting of shareholders of the company for deliberation.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) disclosed by the company on the same day Announcement of Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 annual profit distribution plan (Announcement No.: 2022017) VI. the proposal on the special report on the deposit and actual use of the company’s raised funds in 2021 was deliberated and passed
The deposit and use of the raised funds of the company in 2021 comply with the relevant provisions and regulatory policies of the China Securities Regulatory Commission and Shanghai Stock Exchange on the deposit and use of the raised funds of listed companies, and there is no illegal deposit and use of the raised funds, The special report on the deposit and actual use of raised funds in Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 truthfully reflects the actual situation of the company’s deposit and use of raised funds in 2021. Therefore, we agree with the contents of the above-mentioned special report.
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) disclosed by the company on the same day Special report on the deposit and actual use of raised funds in Shan Dong Kexing Bioproducts Co.Ltd(688136) 2021 (Announcement No.: 2022018).
It is hereby announced.
Shan Dong Kexing Bioproducts Co.Ltd(688136) board of supervisors April 19, 2022
